Literature DB >> 1518020

Hereditary haemorrhagic telangiectasia: a clinical analysis.

M E Porteous1, J Burn, S J Proctor.   

Abstract

Data from 98 patients with hereditary haemorrhagic telangiectasia (HHT) are presented. All were symptomatic by 40 years of age and 62% by 16 years. Nose bleeding was the first symptom of disease in 90% of cases with mucocutaneous telangiectases appearing 5 to 20 years later. Complications of HHT are discussed and an age of onset curve given.

Entities:  

Mesh:

Year:  1992        PMID: 1518020      PMCID: PMC1016055          DOI: 10.1136/jmg.29.8.527

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  9 in total

1.  A family reunion: a study of hereditary hemorrhagic telangiectasia.

Authors:  R M BIRD; J F HAMMARSTEN; R A MARSHALL; R R ROBINSON
Journal:  N Engl J Med       Date:  1957-07-18       Impact factor: 91.245

2.  Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population.

Authors:  H Plauchu; J P de Chadarévian; A Bideau; J M Robert
Journal:  Am J Med Genet       Date:  1989-03

3.  Hereditary hemorrhagic telangiectasia; review of 102 cases and presentation of an innovation to septodermoplasty.

Authors:  R H Stecker; C F Lake
Journal:  Arch Otolaryngol       Date:  1965-11

4.  Fiberoptic bronchoscope and Nd-YAG laser in treatment of severe epistaxis from nasal hereditary hemorrhagic telangectasia and hemangioma.

Authors:  A C Mehta; D R Livingston; H L Levine
Journal:  Chest       Date:  1987-05       Impact factor: 9.410

5.  Pulmonary scintigraphy in a patient with multiple pulmonary arteriovenous malformations and pulmonary embolism.

Authors:  J A Harding; M G Velchik
Journal:  J Nucl Med       Date:  1985-02       Impact factor: 10.057

6.  Hereditary hemorrhagic telangiectasia in three black men.

Authors:  D B Posner; R E Sampliner
Journal:  Am J Gastroenterol       Date:  1978-10       Impact factor: 10.864

7.  Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia.

Authors:  P Vase; M Holm; H Arendrup
Journal:  Acta Med Scand       Date:  1985

8.  Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy.

Authors:  R I White; A Lynch-Nyhan; P Terry; P C Buescher; E J Farmlett; L Charnas; K Shuman; W Kim; M Kinnison; S E Mitchell
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

9.  Cerebral embolism--first manifestation of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.

Authors:  R C Hewes; M Auster; R I White
Journal:  Cardiovasc Intervent Radiol       Date:  1985       Impact factor: 2.740

  9 in total
  45 in total

1.  A woman with an unusual case of hemoptysis.

Authors:  Narinder Pal Singh; Sameer Gulati; Sandeep Garg; Pankaj Beniwal
Journal:  CMAJ       Date:  2006-08-01       Impact factor: 8.262

2.  Video-assisted simultaneously stapled segmentectomy for pulmonary arteriovenous malformation located in the pulmonary hilum.

Authors:  Shunsuke Yamada; Daisuke Masuda; Hiroshi Inoue
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-12

Review 3.  Hereditary hemorrhagic telangiectasia.

Authors:  Anne Grand'Maison
Journal:  CMAJ       Date:  2009-04-14       Impact factor: 8.262

4.  Recurrent epistaxes in hereditary haemorrhagic telangiectasia.

Authors:  S M Lim; R J Lane
Journal:  J R Soc Med       Date:  1997-05       Impact factor: 5.344

5.  Rare manifestations in a case of Osler-Weber-Rendu disease.

Authors:  Abhijai Singh; Vikas Suri; Sanjay Jain; Subhash Varma
Journal:  BMJ Case Rep       Date:  2015-01-05

6.  Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: A cross-sectional survey.

Authors:  Shruti Chaturvedi; Marianne Clancy; Nicole Schaefer; Olalekan Oluwole; Keith R McCrae
Journal:  Thromb Res       Date:  2017-03-09       Impact factor: 3.944

7.  The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study.

Authors:  Benedikt J Folz; Ana Cerra Wollstein; Heiko Alfke; Anja A Dünne; Burkard M Lippert; Konrad Görg; Hans-Joachim Wagner; Siegfried Bien; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503

8.  Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.

Authors:  R E Harrison; J A Flanagan; M Sankelo; S A Abdalla; J Rowell; R D Machado; C G Elliott; I M Robbins; H Olschewski; V McLaughlin; E Gruenig; F Kermeen; M Halme; A Räisänen-Sokolowski; T Laitinen; N W Morrell; R C Trembath
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

9.  Hereditary haemorrhagic telangiectasia treated by pulsed neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1,064 nm).

Authors:  A Werner; W Bäumler; S Zietz; T Kühnel; U Hohenleutner; M Landthaler
Journal:  Lasers Med Sci       Date:  2007-11-13       Impact factor: 3.161

Review 10.  Giant spinal perimedullary fistula in hereditary haemorrhagic telangiectasia: diagnosis, endovascular treatment and review of the literature.

Authors:  F Mont'Alverne; M Musacchio; V Tolentino; F Belzile; C Riquelme; A Tournade
Journal:  Neuroradiology       Date:  2003-10-14       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.